Given the fact that the patient AA-1's tumor tissue expressed high levels of EphA2, it is conceivable that tumor-expression of EphA2 has triggered activation of EphA2-reactive CD8+ precursor cells, of which the majority remained as effector memory and central memory T cells. Here, EPHA2 is linked to neoplasm.